Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center Randomized Controlled Study of the Prognosis After Indocyanine Green Fluorescence-guided Radical Surgery in Colorectal Cancer Patients of Stage III

NCT06583564 is registered in ClinicalTrials.gov with Shanghai Tong Ren Hospital as lead sponsor.

NCT NCT06583564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06583564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center Randomized Controlled Study of the Prognosis After Indocyanine Green Fluorescence-guided Radical Surgery in Colorectal Cancer Patients of Stage III
Lead sponsor
Shanghai Tong Ren Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 27, 2024
Completion date
March 31, 2028
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer stage iii